Trial Profile
A Phase II Clinical Trial Study on Apatinib and chemotherapy sequential treatment with advanced metastatic cervical cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 23 Jan 2017 New trial record